Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
35.07
-1.86 (-5.04%)
At close: Aug 20, 2025, 3:59 PM
35.08
0.03%
After-hours: Aug 20, 2025, 04:17 PM EDT

Caris Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
331.64M 309.87M 299.9M
Cost of Revenue
155.31M 139M 125.02M
Gross Profit
176.33M 170.87M 174.88M
Operating Income
202.11M 171.22M 153.39M
Interest Income
n/a n/a n/a
Pretax Income
182.39M 145.88M 123.14M
Net Income
139.08M 103.37M 64.8M
Selling & General & Admin
34.92M 35.7M 39.4M
Research & Development
n/a n/a n/a
Other Expenses
n/a n/a n/a
Operating Expenses
34.92M 35.7M 39.4M
Interest Expense
29.25M 45.88M 52.36M
Selling & Marketing Expenses
-1.15M 5.54M 12.01M
Cost & Expenses
190.24M 174.71M 164.42M
Income Tax Expense
10.43M 8.1M 7.36M
Shares Outstanding (Basic)
17.34M 17.28M 17.27M
Shares Outstanding (Diluted)
17.53M 17.48M 17.52M
EPS (Basic)
8.02 5.95 3.71
EPS (Diluted)
7.92 5.87 3.66
EBITDA
293.62M 269.94M 236.22M
EBIT
156.81M 191.75M 175.5M
Depreciation & Amortization
114.85M 112.59M 111.7M